米国の胃腸内視鏡消毒製品市場：2007年

In 2006, the US market for gastrointestinal endoscope disinfection products generated over $150 million. This market comprises high-level disinfectants, automatic endoscope reprocessors, and enzymatic detergents.

Methodology

The following report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

• Government Sources:
  • Securities and Exchange Commission filings
  • Food and Drug Administration and patent filings
  • National Center for Health Statistics data
• GI Endoscope Disinfection and Sterilization Products Companies:
  • Annual reports, product brochures, corporate profiles, etc.
• Internal Databases and Reports:
  • Previous reports on similar/related sources
• General Internet Searches, Medical Literature and Newspaper/Magazine Searches:
  • Identifying various centers of specialization and articles that might provide leads for primary research.

The secondary research stage builds the foundation for the primary research.

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is, thus, either discarded or marked as high or low priority. It is then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various high level disinfectant market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes [units and US$] and market shares).

Step 3: At this stage, the research is in position for its most important primary phase- expert interviews. Throughout the secondary research, industry and medical experts are identified. These experts are now contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of the particular interviewee, although in most cases, the most important questions are asked of all experts. The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then either augmented, discarded, or adjusted, based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

In addition to Steps 1 through 4 (as outlined above), the following "bottom-up" methodology was followed in developing forecast assumptions for this report.

A comprehensive breakdown of various GI procedures was prepared using data from several sources including professional associations, government statistics, and private research/media sources. Industry experts and practitioners were consulted to ensure accuracy and verify observed trends. As a cross-check, total industry revenues available through 10Ks and other sources were compared against modeled industry revenues.

Using the best estimates of industry experts, practitioners, private research/media sources, and in-house experts, year-by-year growth rates and average selling prices were applied individually to each subcategory to derive forecasts. These estimates were cross-checked by industry experts (marketing managers, product managers, CEOs, etc.) and further refined.

Overall findings were compared against market and procedure forecasts published by other sources to ensure reasonable estimates.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US MARKETS FOR GASTROINTESTINAL ENDOSCOPE DISINFECTION PRODUCTS

• 1.1 Market Overview
• 1.2 Market Analysis
  • 1.2.1 Product Overview
  • 1.2.2 Market Forecast
  • 1.2.3 Market Drivers and Limiters
• 1.3 Competitive Analysis

2.0 GI AUTOMATED ENDOSCOPE REPROCESSOR MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Product Overview
  • 2.2.2 Market Forecast
• 2.3 Competitive Analysis

3.0 OPA SOLUTION MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Product Overview
  • 3.2.2 Market Forecast
• 3.3 Competitive Analysis

4.0 PERACETIC ACID SOLUTION MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Product Overview
  • 4.2.2 Market Forecast
• 4.3 Competitive Analysis

5.0 ENZYMATIC DETERGENT MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Product Overview
  • 5.2.2 Market Forecast
• 5.3 Competitive Analysis

6.0 GLUTARALDEHYDE SOLUTION MARKET

• 6.1 Market Overview
• 6.2 Market Analysis
  • 6.2.1 Product Overview
  • 6.2.2 Market Forecast
• 6.3 Competitive Analysis

MRG ACRONYMS AND INITIALISMS

• Exhibit ES-1: Manual versus Automatic GI Endoscope Disinfection Procedures, US, 2006 and 2010
• Exhibit ES-2: Unit Volumes versus Installed Base of GI AERs, US, 2006 and 2011
• Exhibit ES-3: OPA Solution Market versus Glutaraldehyde Market, as a % of Total, US, 2005- 2011
• Exhibit ES-4: Glutaraldehyde, PAA, and OPA Markets, US, 2006 and 2011
• Exhibit ES- 5: Enzymatic Detergent Market versus GI Endoscopy Procedures, US, 2005- 2011
• Exhibit ES-6: Glutaraldehyde Market versus Other HLDs, US, 2006 and 2011
• Exhibit ES-7: Leading Competitors in the GI Endoscope Disinfection Market, US, 2006

• Exhibit 1-1: GI Endoscope Disinfection Product Market, US (US$), 2005- 2011
• Exhibit 1-2: GI Endoscope Disinfection Product Overview, US, 2006
• Exhibit 1-3: Unavailable GI Endoscope Disinfection Products, Overview, US, 2006
• Exhibit 1-4: GI Endoscope Disinfection Product Market, by Segment, US (US$), 2005- 2011
• Exhibit 1-5: Drivers of the US GI Endoscope Disinfection Product Market
• Exhibit 1-6: Limiters of the US GI Endoscope Disinfection Market
• Exhibit 1-7: Leading Competitors in the GI Endoscope Disinfection Market, 2006

• Exhibit 2-1: GI AER Market, US (US$), 2005- 2011 (Graphical Format)
• Exhibit 2-2: GI AER Market, US (US$), 2005- 2011 (Tabular Format)
• Exhibit 2-3: Leading Competitors in the GI Endoscope Reprocessor Market, US, 2006

• Exhibit 3-1: OPA Solution Market, US (US$), 2005- 2011 (Graphical Format)
• Exhibit 3-2: OPA Solution, US (US$), 2005- 2011 (Tabular Format)
• Exhibit 3-3: Leading Competitors in the OPA Market, US, 2006

• Exhibit 4-1: PAA Solution Market, US (US$), 2005- 2011 (Graphical Format)
• Exhibit 4-2: PAA Solution Market, US (US$), 2005- 2011 (Tabular Format)
• Exhibit 4-3: Leading Competitors in the PAA Solution Market, 2006

• Exhibit 5-1: Enzymatic Detergent Market, US (US$), 2005- 2011 (Graphical Format)
• Exhibit 5-2: Enzymatic Detergent Market, US (US$), 2005- 2011 (Tabular Format)
• Exhibit 5-3: Leading Competitors in the Enzymatic Detergent Market, US, 2006

• Exhibit 6-1: Glutaraldehyde Solution Market, US (US$), 2005- 2011 (Graphical Format)
• Exhibit 6-2: Glutaraldehyde Solution Market, US (US$), 2005- 2011 (Tabular Format)
• Exhibit 6-3: Leading Competitors in the Glutaraldehyde Solution Market, US, 2006